12/4
10:20 pm
abcl
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
Neutral
Report
AbCellera Biologics Inc (ABCL) Down 23% Since Q3 2025 Results [Yahoo! Finance]
11/26
04:31 pm
abcl
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL) is a Buy at Stifel Nicolaus despite Wider Q3 Net Loss [Yahoo! Finance]
11/18
06:32 am
abcl
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]
Low
Report
Why Wall Street Maintains Buy Stance on AbCellera Biologics Inc. (ABCL) Amid Business Model Evolution? [Yahoo! Finance]
11/10
10:57 am
abcl
The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
Low
Report
The Best Canadian Stock You've Never Heard of [Yahoo! Finance Canada]
11/10
09:00 am
abcl
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
Medium
Report
AbCellera Appoints Dr. Stephen Quake to its Board of Directors
11/9
05:03 am
abcl
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]
Medium
Report
Assessing AbCellera Biologics (ABCL) Valuation Following Phase 1 Trial Progress and Clinical Milestones [Yahoo! Finance]
11/8
01:18 pm
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at
Wall Str
11/8
06:57 am
abcl
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) was downgraded by analysts at Leerink Partnrs from a "strong-buy" rating to a "hold" rating.
11/7
08:07 am
abcl
AbCellera Biologics (NASDAQ:ABCL) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $4.00 price target on the stock.
Medium
Report
AbCellera Biologics (NASDAQ:ABCL) had its "market perform" rating reaffirmed by analysts at Leerink Partners. They now have a $4.00 price target on the stock.
11/6
04:16 pm
abcl
AbCellera Biologics GAAP EPS of -$0.19 misses by $0.02, revenue of $8.96M beats by $2.63M [Seeking Alpha]
Low
Report
AbCellera Biologics GAAP EPS of -$0.19 misses by $0.02, revenue of $8.96M beats by $2.63M [Seeking Alpha]
11/6
04:05 pm
abcl
AbCellera Reports Q3 2025 Business Results
Medium
Report
AbCellera Reports Q3 2025 Business Results
10/21
10:55 pm
abcl
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL): A Bull Case Theory [Yahoo! Finance]
10/7
04:05 pm
abcl
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
Medium
Report
AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
10/6
07:36 am
abcl
AbCellera Biologics: Entering Growth Phase After A Pause [Seeking Alpha]
Low
Report
AbCellera Biologics: Entering Growth Phase After A Pause [Seeking Alpha]
10/4
09:12 am
abcl
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline [Yahoo! Finance]
Medium
Report
AbCellera (ABCL) Is Up 24.5% After Strong Q2 Revenue Beat and Advancing Clinical Pipeline [Yahoo! Finance]
10/3
02:36 pm
abcl
AbCellera Biologics (NASDAQ:ABCL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
AbCellera Biologics (NASDAQ:ABCL) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
9/29
04:05 pm
abcl
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
Medium
Report
AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025
9/29
02:05 pm
abcl
AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
Low
Report
AbCellera Biologics Inc. (ABCL) is a Great Momentum Stock: Should You Buy? [Yahoo! Finance]
9/21
09:35 am
abcl
New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)'s Push Into Immunology and Beyond [Yahoo! Finance]
Medium
Report
New CMO Appointment Strengthens AbCellera Biologics Inc. (ABCL)'s Push Into Immunology and Beyond [Yahoo! Finance]
9/20
03:08 am
abcl
AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer [Yahoo! Finance]
Medium
Report
AbCellera Biologics Inc. (ABCL) Appoints Chief Medical Officer [Yahoo! Finance]
9/15
08:31 am
abcl
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 [Yahoo! Finance]
Low
Report
TD Cowen Reiterates Buy Rating on ABCL After AbCellera Biologics Dosed First Participants of ABCL575 [Yahoo! Finance]
9/10
09:07 am
abcl
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer
Low
Report
AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer